Similarly, for subjects with average levels of IL-6 at post-treatment, every 10% increase in IL-6 at T2 was associated with a 1.1% decrease in severity of cognitive symptoms of depression (b = −.112, t [20] = -2.720, p = .013). The gene discussed is IL6; the disease is depressive symptom measurement.